Intradermal HPV peptide vaccination
US9562075B2 · kind B2 · utility
3Cited by
11References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2008 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Nov 22, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a peptide derived from HPV-E2, E6 and/or E7 protein for the manufacture of a medicament for the treatment or prevention of an HPV related disease, wherein the medicament is for intradermal administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.